Loading...
•
Mar 30, 2024
Henry Schein Q1 2024 Earnings Report
Henry Schein reported solid earnings, driven by gross margin expansion and recovery from a cyber incident.
Key Takeaways
Henry Schein's first-quarter financial results for 2024 reflect solid earnings driven by gross margin expansion and a strong recovery from last quarter’s cyber incident. The company reported a sales growth of 3.7% compared to the first quarter of 2023.
First-quarter 2024 sales growth of 3.7%.
GAAP diluted EPS of $0.72 and non-GAAP diluted EPS of $1.10.
Total sales growth guidance range tightened to 8% to 10%.
2024 non-GAAP diluted EPS guidance of $5.00 to $5.16 is affirmed and 2024 Adjusted EBITDA growth of more than 15%.
Henry Schein
Henry Schein
Henry Schein Revenue by Segment
Henry Schein Revenue by Geographic Location
Revenue by Segment
Global Dental Revenue
CapyFin.comGlobal Medical Revenue
CapyFin.comGlobal Specialty Products Revenue
CapyFin.comRevenue by Geographic Location
U.S. Distribution and Value-Added Services Revenue
CapyFin.comInternational Distribution and Value-Added Services Revenue
CapyFin.com Forward Guidance
Henry Schein expects 2024 non-GAAP diluted EPS to be $5.00 to $5.16, total sales growth to be approximately 8% to 10%, and Adjusted EBITDA to increase by more than 15%.
Positive Outlook
- 2024 non-GAAP diluted EPS attributable to Henry Schein, Inc. is expected to be $5.00 to $5.16, unchanged from prior guidance, reflecting growth of 11% to 15% compared with 2023 non-GAAP diluted EPS of $4.50.
- 2024 total sales growth is now expected to be approximately 8% to 10% over 2023, compared with prior guidance of 8% to 12% growth.
- This reflects continued recovery from last year’s cyber incident and a strong pipeline of new specialty products and software innovation.
- 2024 Adjusted EBITDA is expected to increase by more than 15% compared with 2023, unchanged from prior guidance.
Revenue & Expenses
Visualization of income flow from segment revenue to net income